As an assistant professor in the Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation at Thomas Jefferson University, I am focused on building a career dedicated to the advancement of care of patients with myeloid malignancies, particularly AML and MDS. My specific research interest is in early-phase clinical trials utilizing novel targeted agents and on novel combinations with conventional chemotherapy. I have designed and initiated investigator initiated clinical trials in conjunction with collaborating laboratory colleagues where I serve as PI and seek to improve patient management and further the mechanistic understanding of novel agents and therapy resistance mechanisms in AML and MDS. I also serve as PI on industry sponsored and cooperative group clinical trials. To gain essential skills in clinical trial design and implementation, I am pursuing formalized training in clinical trial design, epidemiology, biostatistical methods and research ethics through a Master’s degree in Human Investigation through the Jefferson College of Biomedical sciences.

Medical School

Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, 2013

Residency

Thomas Jefferson University Hospital, Philadelphia, PA, 2016
Chief Medical Residency, Thomas Jefferson University Hospital, Philadelphia, PA, 2017

Fellowship

Hematology and Medical Oncology, Thomas Jefferson University Hospital, Philadelphia, PA, 2020